List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 35 studies with search of: Open Studies | "Arthritis, Psoriatic"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting A Study to Investigate the Use of Simponi® in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
Conditions: Arthritis, Rheumatoid;   Arthritis, Psoriatic;   Spondylitis, Ankylosing
Intervention: Drug: Simponi®
2 Recruiting A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Conditions: Psoriasis;   Arthritis, Psoriatic
Interventions: Drug: CP-690,550;   Drug: CP-690, 550
3 Recruiting Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
Conditions: Arthritis, Psoriatic;   Psoriasis
Intervention: Other: questionnaire
4 Recruiting A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
Condition: Arthritis, Psoriatic
Interventions: Drug: placebo;   Drug: ustekinumab
5 Recruiting Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy
Condition: Arthritis, Psoriatic
Interventions: Biological: Placebo matching BMS-945429;   Biological: BMS-945429
6 Recruiting Belgian Registry of HUMIRA (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention: Biological: HUMIRA (adalimumab)
7 Recruiting TIght COntrol of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Intensive management or Tight control;   Drug: Standard management - Control group
8 Recruiting Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis
Conditions: Psoriatic Arthritis;   Psoriasis
Intervention:
9 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
10 Recruiting Biologic Rheumatology Registry Across Canada
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic
Intervention:
11 Recruiting Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: AIN457A
12 Recruiting Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Conditions: Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
13 Recruiting AMG 827 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: AMG 827;   Drug: Placebo
14 Recruiting Efficacy and Safety of Humira in Patients With Psoriatic Arthritis in Normal Medical Practice
Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
15 Recruiting Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention:
16 Recruiting Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab (75 mg);   Biological: Secukinumab (150 mg);   Biological: Placebo Comparator
17 Not yet recruiting Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine
Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
18 Recruiting Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [PSA, PALACE 4]
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast;   Drug: • Placebo
19 Recruiting Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Conditions: Psoriasis;   Arthritis, Psoriatic
Interventions: Biological: ustekinumab;   Biological: Biological therapies other than infliximab and ustekinumab;   Drug: conventional systemic agents;   Biological: infliximab
20 Recruiting National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study
Condition: Psoriatic Arthritis
Interventions: Drug: Methotrexate;   Drug: Anti-TNF

Previous Page Studies Shown (1-20) Next Page (21-35)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services